CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- 4 Open-market sale Director sold 6,700,000 shares at $3.09 ($20,703,000)
- 4 Open-market sale Director sold 20,221 shares at $4.06 ($82,097)
- 4 Insider Changes in Ownership
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Other disposition Director disposed of 287,756 shares (other)
- 4 Grant or award Chief Administrative Officer acquired 98,037 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Director gave up 311,128 shares (to pay taxes)
- 4 Conversion Director acquired 779,900 shares (conversion)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Director sold 750,000 shares at $3.05 ($2,287,500)
- S-3 Offering Registration Statement
- 4 Open-market sale Director sold 1,976,137 shares at $2.87 ($5,672,106)
Page 6 of 28 · 548 filings